Navigation Links
German-Polish physicist duo win 2014 Copernicus Award
Date:5/13/2014

tion in quantum cryptography and quantum metrology. Weinfurter has received numerous awards for his work, including the Philip Morris Prize for Research in 2003 and the Descartes Prize from the European Union in 2004. He has been a Max Planck Fellow at the Max-Planck-Institute of Quantum Optics in Garching since 2010 and is associated with Nobel Laureate Professor Theodor W. Hnsch's Department of Laser Spectroscopy.

Professor Marek Żukowski has been professor of physics since 1998 at the University of Gdansk. Initially appointed as associate professor, he has held a chair since 2006. He was head of the Department for Quantum Optics at the Institute for Physics at the University of Gdansk from 1996 to 2005 and is now head of the Institute. He habilitated in Torun in Poland, at the Nikolaus Kopernikus University, after achieving a "Proficiency Certificate in English grade A" in Cambridge in the UK. His doctorate in Gdansk followed a course of study in both physics and mathematics. Żukowski is a founding member of the National Quantum Information Centre of Gdansk, which was established in 2007, and since 2010 a member of the board of the National Centre for Science, a research funding organisation. He has received the Prize for Science from the Polish Ministry for Education four times and has been awarded prizes by the Rector of Gdansk University three times. Periods as a visiting professor in Beijing, China and the award in 2006 of a Wenner Gren Fellowship from Sweden, like his many years of collaboration with Professor Weinfurter, underline his position in a widely international network.

The two physicists are the fifth pair to receive the Copernicus Award from the DFG and the FNP, which since 2006 has been conferred every two years to two researchers, one from Germany and one from Poland. The award is named after the astronomer Nicolas Copernicus (1473-1543) and is intended to symbolise the close collaboration between the countries on r
'/>"/>

Contact: Marco Finetti
marco.finetti@dfg.de
49-228-885-2230
Deutsche Forschungsgemeinschaft
Source:Eurekalert

Page: 1 2 3

Related biology news :

1. Copernicus Award 2012 for German-Polish collaboration in business information systems
2. Physicists explore properties of electrons in revolutionary material
3. Biophysicists unravel secrets of genetic switch
4. Cancer is a result of a default cellular safe mode, physicist proposes
5. Physicists decode decision circuit of cancer metastasis
6. Physicists provide new insights into coral skeleton formation
7. Physicists delve into fundamental laws of biological materials
8. New therapies targeting cancer, Alzheimers goal of UH physicist
9. Keck award enables Carnegie Mellon and Stanford to dramatically expand crowdsourced RNA design
10. MARC travel awards announced for EB 2012
11. Space research institute honors Sen. Hutchison with Pioneer Award
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/12/2015)... Minn. , Feb. 12, 2015   ... company specializing in clinical study management systems, has ... Program , further distinguishing iMedNet ... Clinical Research Organizations (CROs) and healthcare consultants.  Building ... support, prospective customer referrals and numerous co-marketing opportunities), ...
(Date:2/9/2015)... , Feb. 9, 2015  Lintec of America ... methods for carbon nanotube (CNT) macrostructures, including sheets, yarns ... Dallas (UTD). Leveraging the vast industrial resources ... Tokyo, Japan , Lintec of America is forming ... Richardson, TX , focusing on scaling up the ...
(Date:2/5/2015)... 26, 2015 NXT-ID, Inc. (NASDAQ: NXTD ... authentication company focused on the growing mobile commerce market, ... http://www.nxt-id.com/ ) as part of its 2015 marketing and ... launched its new consumer website for Wocketwallet.com earlier this ... of NXT-ID said, "Our new corporate website naturally showcases ...
Breaking Biology News(10 mins):MedNet Solutions Announces Key Enhancements To Its iMedNet Partner Program 2Lintec announces exclusive license to commercialize innovative carbon nanotube technology from the University of Texas at Dallas 2Lintec announces exclusive license to commercialize innovative carbon nanotube technology from the University of Texas at Dallas 3Lintec announces exclusive license to commercialize innovative carbon nanotube technology from the University of Texas at Dallas 4NXT-ID, Inc. Launches New Corporate Website As Part Of Ongoing 2015 Branding Initiatives For Wocket Smart Wallet 2NXT-ID, Inc. Launches New Corporate Website As Part Of Ongoing 2015 Branding Initiatives For Wocket Smart Wallet 3
... of Leicester archaeologist has discovered a bone belonging to ... to be the earliest archaeological evidence of a tortoise ... Post-Medieval Archaeology (volume 44/1) by University of ... find is in the insights it gives on the ...
... cellulosic biofuels commercially viable is to cost-effectively deconstruct ... U.S. Department of Energy (DOE) is funding several ... optimally degrade cellulosic feedstocks. One such source are ... litter in forests; in fact, some pest management ...
... The Timken Company (NYSE: TKR ) has ... offering a broader selection of options and features to better resist ...  The new dental bearings employ stainless steel rings, high-quality Grade 3 ... , , ...
Cached Biology News:Archaeology find sheds new light on family pets 2Breaking biomass better 2Timken Enhances Dental Bearing Offering 2Timken Enhances Dental Bearing Offering 3
(Date:2/26/2015)... On behalf of biotech client GenScript ... Goldman & Spitzer, P.A. (Wilentz) secured a significant jury ... in excess of $10 million. The jury determined that ... that it improperly hired one or more of GenScript,s ... judgment notwithstanding the verdict, a new trial, and remittitur. ...
(Date:2/26/2015)... 2015   Regulus Therapeutics Inc . (NASDAQ: ... and development of innovative medicines targeting microRNAs, today announced ... Chief Executive Officer of Regulus, will present a company ... Annual Healthcare Conference on Wednesday, March 4, 2015 at ... the Boston Marriott Copley Place.  The ...
(Date:2/26/2015)... On behalf of biotech client GenScript USA, ... & Spitzer, P.A. (Wilentz) secured a significant jury ... in excess of $10 million. The jury determined that ... that it improperly hired one or more of GenScript’s ... for judgment notwithstanding the verdict, a new trial, and ...
(Date:2/26/2015)... Pittsburgh, PA (PRWEB) February 26, 2015 ... March 9 -12, at the Ernest N. Morial ... 919 exhibitors (count as of February 19, 2015) ... community in industrial, academic, and government labs. The ... such as, but not limited to, analytical chemistry; ...
Breaking Biology Technology:Wilentz Client GenScript Awarded $10 Million in Trade Secrets Case Against Genewiz 2Wilentz Client GenScript Awarded $10 Million in Trade Secrets Case Against Genewiz 3Regulus to Present at Cowen and Company 35th Annual Healthcare Conference 2Regulus to Present at Cowen and Company 35th Annual Healthcare Conference 3Wilentz Client GenScript Awarded $10 Million in Trade Secrets Case Against Genewiz 2Wilentz Client GenScript Awarded $10 Million in Trade Secrets Case Against Genewiz 3Pittcon 2015 Announces Exposition Highlights 2
... ViroPharma Incorporated,(Nasdaq: VPHM ) today announced that ... will present at the Goldman Sachs 29th,Annual Global ... June 10,2008. The conference is being held at ... ViroPharma also announced that William Roberts, vice president,corporate ...
... June 3 Exelixis,Inc. (Nasdaq: EXEL ) announced ... officer of Exelixis, will present at the Goldman Sachs,29th ... ET on,Tuesday, June 10, 2008. Dr. Scangos will discuss ... The presentation will be webcast and may be accessed ...
... VANCOUVER, June 3 /PRNewswire-FirstCall/ - Angiotech Pharmaceuticals,Inc. (NASDAQ: ... pharmaceutical and,medical device company, today announced the completion ... lung biopsy track plug., "Our proprietary Bio-Seal ... used to diagnose lung cancer," said Dr.,William Hunter, ...
Cached Biology Technology:ViroPharma to Present at Two Upcoming Healthcare Conferences 2Angiotech announces completion of Bio-Seal(TM) clinical trial enrolment 2Angiotech announces completion of Bio-Seal(TM) clinical trial enrolment 3Angiotech announces completion of Bio-Seal(TM) clinical trial enrolment 4